Research ArticleMalaria

Malaria in pregnancy alters l-arginine bioavailability and placental vascular development

See allHide authors and affiliations

Science Translational Medicine  07 Mar 2018:
Vol. 10, Issue 431, eaan6007
DOI: 10.1126/scitranslmed.aan6007

Malaria relief, one amino acid at a time

Malaria infection during pregnancy can disrupt placental vasculature and cause complications during the pregnancy and delivery. Nitric oxide plays a key role in placental vascular function, and its synthesis requires l-arginine. Knowing that l-arginine and nitric oxide are both depleted during malaria-induced hemolysis and that many people in malaria-endemic areas lack sufficient l-arginine in their diets, McDonald et al. examined the effects of dietary l-arginine supplementation. The authors first studied a cohort of pregnant women in Malawi and showed that the blood of patients with malaria had less l-arginine and that this was associated with worse pregnancy outcomes. Conversely, l-arginine supplementation in a mouse model of malaria in pregnancy improved fetal weight and viability, indicating the potential value of this intervention.

This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.